Latest news

Kinesis Pharma will prepare a paediatric investigational plan for a compound for treatment of an orphan disease.

Kinesis Pharma will prepare a paediatric investigational plan for a compound, currently in clinical development for treatment of an orphan disease.

Kinesis also participates in the non-clinical development and in the trial coordination of the clinical studies for this compound. In later stage, Kinesis will assist in preparation of the eCTD dossier for filing to the EMA.


Back to news overview

Print this page